3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Tuberous Sclerosis
3
Seizures
2
Lennox Gastaut Syndrome
2
Epilepsies, Myoclonic
2
Prostatic Neoplasms
1
Neoplasms
1
Marijuana Abuse
1
Liver Cirrhosis
1
Glioblastoma
1
Carcinoma, Intraductal, Noninfiltrating
1
Cancer Pain
1
Breast Carcinoma In Situ
1
Behavior
1
Interventions
resiniferatoxin
1
cannabichromene
1
Transcranial Direct Current Stimulation
1
Telemedicine
1
Surveys and Questionnaires
1
Spinal Cord Stimulation
1
Radiosurgery
1
Patient Education as Topic
1
Oxycodone
1
Electroacupuncture
1
Dronabinol
1
Cannabidiol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cancer Pain
×
Cannabidiol
×
90 days
×
Clear all
NCT06533657
2026-04-21
UTOPIA-1
ZYUS Life Sciences Inc.
Phase 2
Completed
11 enrolled